Mitochondrial medicine - Recent advances

Journal of Internal Medicine

Volumn 246, Issue 1, 1999, Pages 11-23

  Graff, C ^a   Clayton, D A ^b   Larsson, Nils Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Ageing; Diabetes mellitus; Genetics; Mitochondrial diseases; Neurodegenerative diseases; Radical oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; MENADIONE; MITOCHONDRIAL DNA; NICOTINAMIDE; PEPTIDE NUCLEIC ACID; RIBOFLAVIN; SUCCINIC ACID; TOCOPHEROL; UBIQUINONE;

AGING; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENCEPHALOMYOPATHY; GENE MUTATION; GENE THERAPY; HEART FAILURE; HUMAN; LABORATORY DIAGNOSIS; MITOCHONDRION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SYSTEMIC DISEASE;

EID: 0032794209     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00514.x     Document Type: Review

References (108)

1. Altmann R. Die Elementarorganismen und lhre Berziehungen Zu Den Zellen. Leipzig: Verlag von Veit, 1890.
2. Lang BF, Burger G, O'Kelly CJ et al. An ancestral mitochondrial DNA resembling a eubacterial genome in miniature. Nature 1997; 387: 493-97.
3. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance or mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962; 41: 1776-804.
4. Nass MMK, Nass S. Intramitchondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 1963; 19: 593-611.
5. Anderson S, Bankier AT, Barell BG et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
6. Bibb MJ, Van Etten RA, Wright CT, Walberg MW, Clayton DA. Sequence and organization of mouse mitochondrial DNA. Cell 1981; 26: 167-80.
7. Holt IJ. Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-19.
8. Wallace DC, Singh G, Lott MT et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-30.
9. Larsson NG, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Annu Rev Genet 1995; 29: 151-78.
10. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256: 628-32.
11. Luft R. The development or mitochondrial medicine. Proc Natl Acad Sci USA 1994; 91: 8731-38.
12. Luft R, Landau BR. Mitochondrial medicine. J Intern Med 1995; 238: 405-21.
13. Benda C. Über die Spermatogenese der Vertebraten und höheren Evertebralen. II. Theil. Die Histiogenese der Spermien. Archive für Anatomie und Physiologie. Physiologische Abt 1898; 393-98.
14. Clayton DA. Replication and transcription or vertebrate mitochondrial DNA. Annu Rev Cell Biol 1991; 7: 453-78.
15. Giles RE, Blanc H, Cann HM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 1980; 77: 6715-19.
16. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 1997; 13: 450-55.
17. Larsson NG, Tulinius MH, Holme E et al. Segregation and manifestations of the mtDNA tRNALys A→G (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1992; 51: 1201-12.
18. Jenuth JP, Peterson AC, Fu K, Shoubridge EA. Random genetic drill in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat Genet 1996; 14: 146-51.
19. Rustin P, Chretien D, Bourgeron T et al. Assesment of the mitochondrial respiratory chain. Lancet 1991; 338: 60.
20. Oldfors A, Holme E, Kristiansson B et al. The correlation between pathology, biochemistry and molecular genetics in mitochondrial encephalomyopathies. In: Gorrod JW, Albano O, Ferrari E, Papa S, eds. Molecular Basis of Neurological Disorders and Their Treatment, London, UK: Chapman & Hall 1991: 243-54.
21. Engel WK, Cunningham GG. Rapid examination or muscle tissue. Neurology 1963; 13: 919-23.
22. Sciacco M, Bonilia E, Schon EA, DiMauro S, Moraes CT. Distribution of wild-type and common deletion forms of mtDNA in normal and respiratory-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet 1994; 3: 13-19.
23. Larsson NG, Wang J, Wilhelmsson H et al. Mitochondrial transcription faclor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 1998; 18: 231-36.
24. Chee M, Yang R, Hubbell E et al. Accessing genetic information with high-density DNA arrays. Science 1996; 274: 610-14.
25. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 631-51.
26. Lys matation. Cell 1990; 61: 931-37.
27. Zeviani M, Moraes CT, DiMauro S et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 18: 1139-46.
28. Lestienne P, Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1988; i: 885.
29. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 1989; 244: 346-49.
30. Moraes CT, DiMauro S, Zeviani M et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-99.
31. Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 1995; 4: 1327-30.
32. Munnich A, Rotig A, Chretien D, Saudubray JM, Cormier V, Rustin P. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Pediatr 1996; 155: 262-74.
33. Larsson NG, Holme E, Kristiansson B. Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990; 28: 131-36.
34. Nikoskelainen EK, Savontaus M-L, Wanne OP, Katila MJ, Nummelin KU. Leber's hereditary optic neuroretinopathy, a maternally inheriled disease. Arch Opthalmol 1987; 105: 665-71.
35. Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus M-L. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1991; 48: 1146-53.
36. Howell N, Bindoff LA, McCullough DA et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991; 49: 939-50.
37. Savontaus ML, mtDNA mutations in Leber's hereditary optic neuropathy. Biochim Biophys Acta 1995; 1271: 261-63.
38. Larsson NG, Andersen O, Holme E, Oldfors A, Wahlström J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 1991; 30: 701-708.
39. Majander A, Huoponen K, Savontaus M-L, Nikoskelainen E, Wikström M. Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of Leber hereditary optic neuroretinopathy (LHON). FEBS Letters 1991; 292: 289-92.
40. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA. A new mitochondrial disclose associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-33.
41. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucl Acids Res 1990; 18: 6927-33.
42. Cortopassi GA, Shibata D, Soong N-W, Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 1992; 89: 7370-74.
43. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 1992; 2: 324-29.
44. Liu VW, Zhang C, Nagley P. Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. Nucl Acids Res 1998; 26: 1268-75.
45. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989; E 637-39.
46. Cooper JM, Mann VM, Schapira AHV. Analyes of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci 1992; 113: 91-98.
47. Kopsidas G, Kovalenko SA, Kelso JM, Linnane AW. An age- associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle. Mutat Res 1998; 421: 27-36.
48. Mecocci P, MacGarvey U, Kaufman AE et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993; 34: 609-16.
49. Chretien D, Gallego J, Barrientos A et al. Biochemical parameters for the diagnosis of mitochondrial respiratory chain deficiency in humans, and their lack of age-related changes. Biochem J 1998; 329: 249-54.
50. Barrientos A, Casademont J, Rotig A et al. Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem Biophys Res Commun 1996; 229: 536-9.
51. Zucchini C, Pugnaloni A, Pallotti F et al. Human skeletal muscle mitochondria in aging: lack of detectable morphological and enzymic defects. Biochem Mol Biol Int 1995; 37: 607-16.
52. Hayashi J-I, Ohta S, Kikuchi A, Tekemitsu M, Goto Y-I, Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 1991; 88: 10 614-18.
53. Laderman KA, Penny JR, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J Virol Chem 1996; 271: 15891-97.
54. Isobe K, Ito S, Hosaka H et al. Nuclear-recessive mutations of factors involved in mitochondrial translation are responsible for age-related respiration deficiency of human skin fibroblasts. J Biol Chem 1998; 271: 4601-606.
55. Miquel J, Fleming J. Theoretical and experimental support for an 'oxygen radical-mitochondrial injury' hypothesis of cell ageing. In: Johnson JE, ed. Free Radicals, Ageing, and Degenerative Diseases. New York: Alan R. Liss, 1986;51-74.
56. Wallace DC, Melov S. Radicals r'aging. Nat Genet 1998; 19: 105-106.
57. Liu XS, Kim CN, Yang J, Jemmerson R, Wang XD. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
58. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998; 94: 695-98.
59. Parkes TL, Elia AJ, Dickinson D, Hilliker AJ, Phillips JP, Boulianne GL. Extensinn of Drosophila lifespan by over-expression of human SODI in motorneurons. Nat Genet 1998; 19: 171-74.
60. Ishii N, Fujii M, Hartman PS et al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 1998; 394: 694-97.
61. Li YB, Huang TT, Carlson EJ et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995; 11: 376-81.
62. Melov S, Schneider JA, Day BJ et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1999; 18: 159-63.
63. Pramatarova A. Figlewicz DA, Krizus A et al. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995; 56: 592-96.
64. Braunwald E (ed.) Heart Disease: a Textbook of Cardiovascular Medicine. Philadelphia: W.B. Saunders, 1997.
65. Antozzi C, Zeviani M. Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc Res 1997; 35: 184-99.
66. Hattori K, Tanaka M, Sugiyama S et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 1991; 121: 1735-42.
67. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucl Acids Res 1995; 23: 4122-26.
68. Mueller-Hocker J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart - an age-related phenomenon. Am J Pathol 1989; 134: 1167-73.
69. Wallace DC. Diseases of the mitochondrial DNA. Ann Rev Biochem 1992; 61: 1175-212.
70. Leu (UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-71.
71. Reardon W, Ross RJM, Sweeney MG et al. Diabetes mellitus associated with a pathogenetic point mutation in mitochondrial DNA. Lancet 1992; 340: 1376-79.
72. tLeu (UUR) gene. Lancet 1993; 341: 1291-92.
73. Sue CM, Holmes-Walker DJ, Morris JG, Boyages SC, Crimmins DS, Byrne E. Mitochondrial gene mutations and diabetes mellitus. Lancet 1993; 341: 437-38.
74. Leu (UUR) gene mutation. Diabetes 1996; 45: 478-87.
75. Ballinger SW, Shoffner JM, Hedaya EV et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992; 1: 11-15.
76. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC. Mitochondrial diabetes revisited. Nat Genet 1994; 7: 458-59.
77. Alcolado JC, Alcolado R. Importance of maternal history of non-insulin dependent diabetic patients. Br Med J 1991; 302: 1178-80.
78. Soejima A, Inoue K, Tokai D et al. Mitochondrial DNA is required for regulation of glucose-stimulated insulin secretion in a mouse pancreatic beta cell line, MIN6. J Biol Chem 1996; 271: 26 194-99.
79. Soong NW, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 1992; 2: 318-23.
80. Ikebe S-I, Tanaka M, Ohno K et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Comm 1990; 170: 1044-48.
81. Ozawa T, Tanaka M, Ino H et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Comm 1991; 176: 938-46.
82. Mizuno Y, Ohta S, Tanaka M et al. Deficiencies in complex 1 subunits of the respiratory chain in Parkinson's disease. Bioch Biophys Res Comm 1989; 163: 1450-55.
83. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991; 30: 332-39.
84. Cavelier L, Jazin EE, Eriksson I et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 1995; 29: 217-24.
85. Shoffner JM, Brown MD, Torroni A et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993; 17: 171-84.
86. Meccocci P, Macgarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1991; 16: 747-51.
87. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219: 979-80.
88. Mizuno Y, Sone N, Saitoh T. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 1987; 48: 1787-93.
89. Miyako K, Kai Y, Irie T, Takeshige K, Kang D. The content of intracellular mitochondrial DNA is decreased by 1-methyl-4- phenylpyridinium ion (MPP+). J Biol Chem 1997; 272: 9605-608.
90. Brown MD, Shoffner JM, Kim YL et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am J Med Genet 1996; 61: 283-89.
91. Bourgeron T, Rustin P, Chretien D et al, Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995; 11: 144-49.
92. van den Heuvel L, Ruitenbeek W, Smeets R et al. Demonstration of a new pathogenic mutation in human complex 1 deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 1998; 62: 262-68.
93. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989; 339: 309-11.
94. Suomalainen A, Kaukonen J, Amati P et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995; 9: 146-51.
95. Kaukonen JA, Amati P, Suomalainen A et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996; 58: 763-69.
96. Larsson NG, Oldfors A, Holme E, Clayton DA. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biophys Biochem Res Comm 1994; 200: 137-81.
97. Bodnar AG, Cooper JM, Holt IJ, Leonard JV, Schapira AHV. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am J Hum Genet 1993; 53: 663-69.
98. Babcock M, de Silva D, Oaks R et al. Regulatinn of mitochondrial iron accumulation by Yfhlp. a putative homolog of frataxin. Science 1997; 276: 1709-12.
99. de Rotig A, Lonlay P, Chretein D et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997; 17: 215-17.
100. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997; 16: 345-51.
101. Lutsenko S, Cooper MJ. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci USA 1998; 95: 6004-6009.
102. Casari G, De Fusco M, Ciarmatori S et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973-83.
103. Campuzano V, Montermini L, Molto MD et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423-27.
104. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr 1994; 14: 535-68.
105. Fadic R, Johns DR. Treatment of the mitochondrial encephalomyopathies. In: Beal MF, Howell N, Bodis-Wollner I, eds. Mitochondria and Free Radicals in Neurodegenerative Diseases. New York, USA: Wiley-Liss, 1997; 517-55.
106. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 1997; 15: 212-15.
107. Clark KM, Bindoff LA, Lightowlers RN et al. Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet 1997; 16: 222-24.
108. Shoubridge EA, Johns T, Karpati G. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet 1997; 6: 2239-42.